{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T01:20:11Z","timestamp":1770254411758,"version":"3.49.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"vor","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"DOI":"10.1186\/s12891-025-09451-9","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T08:25:34Z","timestamp":1767860734000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Denosumab combined with curettage after surgical dislocation of the hip in the treatment of giant cell tumors of bone in the femoral head and neck region: a single-center retrospective study"],"prefix":"10.1186","volume":"27","author":[{"given":"Jimo","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongfeng","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuobin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenfeng","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lvlin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2109-6068","authenticated-orcid":false,"given":"Song","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,8]]},"reference":[{"issue":"5","key":"9451_CR1","doi-asserted-by":"publisher","first-page":"461","DOI":"10.2106\/JBJS.J.01922","volume":"94","author":"X Niu","year":"2012","unstructured":"Niu X, Zhang Q, Hao L, Ding Y, Li Y, Xu H, et al. Giant cell tumor of the extremity: retrospective analysis of 621 Chinese patients from one institution. J Bone Joint Surg Am Volume. 2012;94(5):461\u20137.","journal-title":"J Bone Joint Surg Am Volume"},{"issue":"3","key":"9451_CR2","first-page":"e56929","volume":"16","author":"P Gedekar","year":"2024","unstructured":"Gedekar P, Chavhan A, Hiwale KM, Sagar S. Unusual presentation of a giant cell tumor of the bone: A case report. Cureus. 2024;16(3):e56929.","journal-title":"Cureus"},{"issue":"2","key":"9451_CR3","doi-asserted-by":"publisher","first-page":"e52","DOI":"10.4081\/rt.2009.e52","volume":"1","author":"JL Beebe-Dimmer","year":"2009","unstructured":"Beebe-Dimmer JL, Cetin K, Fryzek JP, Schuetze SM, Schwartz K. The epidemiology of malignant giant cell tumors of bone: an analysis of data from the Surveillance, epidemiology and end results program (1975\u20132004). Rare Tumors. 2009;1(2):e52.","journal-title":"Rare Tumors"},{"key":"9451_CR4","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.canep.2016.03.014","volume":"42","author":"JM Amelio","year":"2016","unstructured":"Amelio JM, Rockberg J, Hernandez RK, Sobocki P, Stryker S, Bach BA, et al. Population-based study of giant cell tumor of bone in Sweden (1983\u20132011). Cancer Epidemiol. 2016;42:82\u20139.","journal-title":"Cancer Epidemiol"},{"key":"9451_CR5","doi-asserted-by":"crossref","unstructured":"Wijsbek AE, Vazquez-Garcia BL, Grimer RJ, Carter SR, Abudu AA, Tillman RM et al. Giant cell tumour of the proximal femur: is joint-sparing management ever successful? Bone Joint J. 2014;96\u2013b(1):127\u201331.","DOI":"10.1302\/0301-620X.96B1.31763"},{"issue":"5","key":"9451_CR6","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s11912-021-01047-5","volume":"23","author":"A Basu Mallick","year":"2021","unstructured":"Basu Mallick A, Chawla SP. Giant cell tumor of bone: an update. Curr Oncol Rep. 2021;23(5):51.","journal-title":"Curr Oncol Rep"},{"key":"9451_CR7","doi-asserted-by":"publisher","first-page":"36332","DOI":"10.1038\/srep36332","volume":"6","author":"P Hu","year":"2016","unstructured":"Hu P, Zhao L, Zhang H, Yu X, Wang Z, Ye Z, et al. Recurrence rates and risk factors for primary giant cell tumors around the knee: A multicentre retrospective study in China. Sci Rep. 2016;6:36332.","journal-title":"Sci Rep"},{"issue":"4","key":"9451_CR8","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.rbo.2015.08.008","volume":"51","author":"RC J\u00fanior","year":"2016","unstructured":"J\u00fanior RC, Pereira MG, Garcia PB, Santos PA, Cavalcanti Ados S, Meohas W. Epidemiological study on giant cell tumor recurrence at the Brazilian National Institute of traumatology and orthopedics. Revista Brasileira De Ortop. 2016;51(4):459\u201365.","journal-title":"Revista Brasileira De Ortop"},{"issue":"11","key":"9451_CR9","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1007\/s00402-009-1026-2","volume":"130","author":"HS Cho","year":"2010","unstructured":"Cho HS, Park IH, Han I, Kang SC, Kim HS. Giant cell tumor of the femoral head and neck: result of intralesional curettage. Arch Orthop Trauma Surg. 2010;130(11):1329\u201333.","journal-title":"Arch Orthop Trauma Surg"},{"issue":"7","key":"9451_CR10","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1177\/014107688607900707","volume":"79","author":"SB Tibrewal","year":"1986","unstructured":"Tibrewal SB. Treatment of giant cell tumour of the femoral head and neck. J R Soc Med. 1986;79(7):401\u20134.","journal-title":"J R Soc Med"},{"key":"9451_CR11","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1097\/00003086-200112000-00032","volume":"393","author":"EK Wai","year":"2001","unstructured":"Wai EK, Davis AM, Griffin A, Bell RS, Wunder JS. Pathologic fractures of the proximal femur secondary to benign bone tumors. Clin Orthop Relat Res. 2001;393:279\u201386.","journal-title":"Clin Orthop Relat Res"},{"issue":"1","key":"9451_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ctrv.2009.09.002","volume":"36","author":"C Errani","year":"2010","unstructured":"Errani C, Ruggieri P, Asenzio MA, Toscano A, Colangeli S, Rimondi E, et al. Giant cell tumor of the extremity: A review of 349 cases from a single institution. Cancer Treat Rev. 2010;36(1):1\u20137.","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"9451_CR13","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jor.2013.12.009","volume":"11","author":"A Nisar","year":"2014","unstructured":"Nisar A, Gulhane S, Mahendra A, Meek RM, Patil S. Surgical dislocation of the hip for excision of benign tumours. J Orthop. 2014;11(1):28\u201336.","journal-title":"J Orthop"},{"key":"9451_CR14","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ejca.2017.02.021","volume":"77","author":"L van der Heijden","year":"2017","unstructured":"van der Heijden L, Dijkstra PDS, Blay JY, Gelderblom H. Giant cell tumour of bone in the denosumab era. Eur J Cancer (Oxford England: 1990). 2017;77:75\u201383.","journal-title":"Eur J Cancer (Oxford England: 1990)"},{"issue":"10","key":"9451_CR15","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1007\/s00402-019-03167-x","volume":"139","author":"G Luengo-Alonso","year":"2019","unstructured":"Luengo-Alonso G, Mellado-Romero M, Shemesh S, Ramos-Pascua L, Pretell-Mazzini J. Denosumab treatment for giant-cell tumor of bone: a systematic review of the literature. Arch Orthop Trauma Surg. 2019;139(10):1339\u201349.","journal-title":"Arch Orthop Trauma Surg"},{"issue":"3","key":"9451_CR16","doi-asserted-by":"publisher","first-page":"230949902097975","DOI":"10.1177\/2309499020979750","volume":"28","author":"VA Singh","year":"2020","unstructured":"Singh VA, Puri A. The current standing on the use of denosumab in giant cell tumour of the bone. J Orthop Surg. 2020;28(3):2309499020979750.","journal-title":"J Orthop Surg"},{"key":"9451_CR17","doi-asserted-by":"crossref","unstructured":"Enneking WF, Dunham W, Gebhardt MC, Malawar M, Pritchard DJ. A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system. Clin Orthop Relat Res. 1993(286):241\u20136.","DOI":"10.1097\/00003086-199301000-00035"},{"issue":"1","key":"9451_CR18","doi-asserted-by":"publisher","first-page":"106","DOI":"10.2106\/00004623-198769010-00018","volume":"69","author":"M Campanacci","year":"1987","unstructured":"Campanacci M, Baldini N, Boriani S, Sudanese A. Giant-cell tumor of bone. J Bone Joint Surg Am Volume. 1987;69(1):106\u201314.","journal-title":"J Bone Joint Surg Am Volume"},{"issue":"1","key":"9451_CR19","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s00264-017-3664-2","volume":"42","author":"DX Lun","year":"2018","unstructured":"Lun DX, Hu YC, Yang XG, Wang Z, Yu XC, Wu SJ, et al. Development and proposal of a scoring system for giant cell tumour of the bone around the knee. Int Orthop. 2018;42(1):203\u201313.","journal-title":"Int Orthop"},{"key":"9451_CR20","doi-asserted-by":"crossref","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). European journal of cancer (Oxford, England: 1990). 2009;45(2):228\u2009\u2013\u200947.","DOI":"10.1016\/j.ejca.2008.10.026"},{"issue":"9","key":"9451_CR21","doi-asserted-by":"publisher","first-page":"2860","DOI":"10.1245\/s10434-015-4634-9","volume":"22","author":"P Rutkowski","year":"2015","unstructured":"Rutkowski P, Ferrari S, Grimer RJ, Stalley PD, Dijkstra SP, Pienkowski A, et al. Surgical downstaging in an open-label phase II trial of denosumab in patients with giant cell tumor of bone. Ann Surg Oncol. 2015;22(9):2860\u20138.","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"9451_CR22","doi-asserted-by":"publisher","first-page":"102520","DOI":"10.5312\/wjo.v16.i3.102520","volume":"16","author":"BG Barreto","year":"2025","unstructured":"Barreto BG, Santili C, Guedes A, Moreira FD, Paz CLD. Denosumab regimens in the treatment of giant cell tumor of bone: A systematic review with meta-analysis. World J Orthop. 2025;16(3):102520.","journal-title":"World J Orthop"},{"issue":"1","key":"9451_CR23","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12957-018-1459-6","volume":"16","author":"H Urakawa","year":"2018","unstructured":"Urakawa H, Yonemoto T, Matsumoto S, Takagi T, Asanuma K, Watanuki M, et al. Clinical outcome of primary giant cell tumor of bone after curettage with or without perioperative denosumab in japan: from a questionnaire for JCOG 1610 study. World J Surg Oncol. 2018;16(1):160.","journal-title":"World J Surg Oncol"},{"key":"9451_CR24","doi-asserted-by":"crossref","unstructured":"Xiang F, Liu H, Deng J, Ma W, Chen Y. Progress on denosumab use in giant cell tumor of bone: dose and duration of therapy. Cancers. 2022;14(23):5758.","DOI":"10.3390\/cancers14235758"},{"key":"9451_CR25","doi-asserted-by":"crossref","unstructured":"Traub F, Singh J, Dickson BC, Leung S, Mohankumar R, Blackstein ME et al. Efficacy of denosumab in joint preservation for patients with giant cell tumour of the bone. European journal of cancer (Oxford, England: 1990). 2016;59:1\u201312.","DOI":"10.1016\/j.ejca.2016.01.006"},{"issue":"10","key":"9451_CR26","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1093\/annonc\/mdv307","volume":"26","author":"T Ueda","year":"2015","unstructured":"Ueda T, Morioka H, Nishida Y, Kakunaga S, Tsuchiya H, Matsumoto Y, et al. Objective tumor response to denosumab in patients with giant cell tumor of bone: a multicenter phase II trial. Annals Oncology: Official J Eur Soc Med Oncol. 2015;26(10):2149\u201354.","journal-title":"Annals Oncology: Official J Eur Soc Med Oncol"},{"issue":"6","key":"9451_CR27","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1111\/os.12561","volume":"11","author":"RZ Zhang","year":"2019","unstructured":"Zhang RZ, Ma TX, Qi DW, Zhao M, Hu T, Zhang GC. Short-term preoperative denosumab with surgery in unresectable or recurrent giant cell tumor of bone. Orthop Surg. 2019;11(6):1101\u20138.","journal-title":"Orthop Surg"},{"issue":"1","key":"9451_CR28","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1186\/s13018-024-05092-1","volume":"19","author":"Z Li","year":"2024","unstructured":"Li Z, Deng Z, Yang Y, Gao D, Zhang Q, Niu X, et al. Denosumab combined with En bloc resection and arthrodesis for recurrent grade 3 giant cell tumor of bone in distal radius. J Orthop Surg Res. 2024;19(1):607.","journal-title":"J Orthop Surg Res"},{"key":"9451_CR29","doi-asserted-by":"publisher","first-page":"100410","DOI":"10.1016\/j.jbo.2021.100410","volume":"32","author":"Y Yang","year":"2022","unstructured":"Yang Y, Xu H, Liu W, Niu X. Study of imaging changes following preoperative denosumab for giant cell tumor of bone. J Bone Oncol. 2022;32:100410.","journal-title":"J Bone Oncol"},{"issue":"4","key":"9451_CR30","first-page":"2112","volume":"31","author":"S Tsukamoto","year":"2024","unstructured":"Tsukamoto S, Mavrogenis AF, Masunaga T, Honoki K, Fujii H, Kido A, et al. Current concepts in the treatment of giant cell tumor of bone: an Update. Current oncology (Toronto. Ont). 2024;31(4):2112\u201332.","journal-title":"Ont)"},{"issue":"6","key":"9451_CR31","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s00590-017-1983-z","volume":"27","author":"C Errani","year":"2017","unstructured":"Errani C, Tsukamoto S, Leone G, Akahane M, Cevolani L, Tanzi P, et al. Higher local recurrence rates after intralesional surgery for giant cell tumor of the proximal femur compared to other sites. Eur J Orthop Surg Traumatology: Orthopedie Traumatologie. 2017;27(6):813\u20139.","journal-title":"Eur J Orthop Surg Traumatology: Orthopedie Traumatologie"},{"issue":"8","key":"9451_CR32","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1302\/0301-620X.83B8.0831119","volume":"83","author":"R Ganz","year":"2001","unstructured":"Ganz R, Gill TJ, Gautier E, Ganz K, Kr\u00fcgel N, Berlemann U. Surgical dislocation of the adult hip a technique with full access to the femoral head and acetabulum without the risk of avascular necrosis. J Bone Joint Surg Br Volume. 2001;83(8):1119\u201324.","journal-title":"J Bone Joint Surg Br Volume"},{"issue":"8","key":"9451_CR33","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.2106\/00004623-200008000-00011","volume":"82","author":"AJ Ramappa","year":"2000","unstructured":"Ramappa AJ, Lee FY, Tang P, Carlson JR, Gebhardt MC, Mankin HJ. Chondroblastoma of bone. J Bone Joint Surg Am Volume. 2000;82(8):1140\u20135.","journal-title":"J Bone Joint Surg Am Volume"},{"issue":"3","key":"9451_CR34","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s00264-009-0779-0","volume":"34","author":"DP Strong","year":"2010","unstructured":"Strong DP, Grimer RJ, Carter SR, Tillman RM, Abudu A. Chondroblastoma of the femoral head: management and outcome. Int Orthop. 2010;34(3):413\u20137.","journal-title":"Int Orthop"},{"issue":"5","key":"9451_CR35","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1002\/jbm.10380","volume":"63","author":"A Ogose","year":"2002","unstructured":"Ogose A, Hotta T, Hatano H, Kawashima H, Tokunaga K, Endo N, et al. Histological examination of beta-tricalcium phosphate graft in human femur. J Biomed Mater Res. 2002;63(5):601\u20134.","journal-title":"J Biomed Mater Res"},{"issue":"11","key":"9451_CR36","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1007\/s00264-018-3922-y","volume":"42","author":"H Liu","year":"2018","unstructured":"Liu H, Fang X, Yu Z, Lang Y, Xiong Y, Duan H. Surgical strategy for benign lesions in proximal femur: internal fixation or endoprosthetic replacement. Int Orthop. 2018;42(11):2691\u20138.","journal-title":"Int Orthop"},{"key":"9451_CR37","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1097\/01.blo.0000181491.39048.fe","volume":"442","author":"Y Farid","year":"2006","unstructured":"Farid Y, Lin PP, Lewis VO, Yasko AW. Endoprosthetic and allograft-prosthetic composite reconstruction of the proximal femur for bone neoplasms. Clin Orthop Relat Res. 2006;442:223\u20139.","journal-title":"Clin Orthop Relat Res"},{"issue":"6","key":"9451_CR38","doi-asserted-by":"publisher","first-page":"612","DOI":"10.5301\/hipint.5000398","volume":"26","author":"HA R\u00fcdiger","year":"2016","unstructured":"R\u00fcdiger HA, Piasecki K, Becce F, Cherix S. Trans-foveal approach for curettage and bone grafting of a giant cell tumour in the femoral head. Hip International: J Clin Experimental Res Hip Pathol Therapy. 2016;26(6):612\u20134.","journal-title":"Hip International: J Clin Experimental Res Hip Pathol Therapy"},{"issue":"6","key":"9451_CR39","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1302\/0301-620X.101B6.BJJ-2018-1599.R1","volume":"101\u2013b","author":"Q Liu","year":"2019","unstructured":"Liu Q, He HB, Zeng H, Yuan YH, Long F, Tian J, et al. Modified trapdoor procedures by surgical dislocation approach to treat chondroblastoma of the femoral head. Bone Joint J. 2019;101\u2013b(6):732\u20138.","journal-title":"Bone Joint J"},{"issue":"4","key":"9451_CR40","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1634\/theoncologist.2016-0192","volume":"22","author":"SP Yang","year":"2017","unstructured":"Yang SP, Kim TW, Boland PJ, Farooki A. Retrospective review of atypical femoral fracture in metastatic bone disease patients receiving denosumab therapy. Oncologist. 2017;22(4):438\u201344.","journal-title":"Oncologist"},{"issue":"5","key":"9451_CR41","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1634\/theoncologist.2013-0432","volume":"19","author":"L van der Heijden","year":"2014","unstructured":"van der Heijden L, Dijkstra PD, van de Sande MA, Kroep JR, Nout RA, van Rijswijk CS, et al. The clinical approach toward giant cell tumor of bone. Oncologist. 2014;19(5):550\u201361.","journal-title":"Oncologist"},{"key":"9451_CR42","doi-asserted-by":"crossref","unstructured":"Tsukamoto S, Righi A, Mavrogenis AF, Akahane M, Honoki K, Tanaka Y et al. Late local recurrence of bone giant cell tumors associated with an increased risk for malignant transformation. Cancers. 2021;13(14):3644.","DOI":"10.3390\/cancers13143644"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12891-025-09451-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-025-09451-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-025-09451-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T11:54:36Z","timestamp":1770206076000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12891-025-09451-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,8]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9451"],"URL":"https:\/\/doi.org\/10.1186\/s12891-025-09451-9","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,8]]},"assertion":[{"value":"13 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Research Ethics Committee of the Affiliated Hospital of Zunyi Medical University (KLL-2024-551) and the process of sample collection was performed based on the guidelines and regulations of the declaration of Helsinki. All identifying information has been meticulously removed or altered to ensure anonymity. The utmost care has been taken to protect the patient\u2019s identity throughout the document. Patients gave their written informed consent for this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. Copies of the consent forms from all patients are available for review by the Editor-in-Chief at any stage.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"100"}}